Functional significance of co-occurring mutations in <i>PIK3CA</i> and <i>MAP3K1</i> in breast cancer
Alvaro Avivar‐Valderas(TiGenix (Spain)), Francisco Cruzalegui(AstraZeneca (United Kingdom))
Cited by 53
Related Papers
No related papers found
Powered by citation graph analysis